MP41-01 IMPACT OF HISTOLOGICAL VARIANTS ON CLINICAL OUTCOMES IN PATIENTS WITH CHEMORESISTANT UROTHELIAL CANCER TREATED WITH PEMBROLIZUMAB: A PROPENSITY SCORE MATCHING ANALYSIS
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI